You just read:

Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant

News provided by

Tarix Pharmaceuticals

Feb 23, 2011, 04:51 ET